secwatch / observer
8-K filed September 7, 2022, 7:59 PM ET ticker CDNA CIK 0001217234
leadership confidence high sentiment neutral materiality 0.55

CareDx appoints Abhishek Jain CFO, Abraham Ronai Chief Admin & Legal Officer; Johnson promoted

CareDx, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Abhishek Jain

Chief Financial Officer
CDNA · CareDx, Inc.
Effective
2022-09-07
Filed
September 7, 2022, 7:59 PM ET
Effective September 7, 2022, CareDx, Inc. (the “Company”) appointed Abhishek Jain, age 46, as the Company’s Chief Financial Officer.
Appointed

Abraham Ronai

Chief Administrative & Legal Officer and Secretary
CDNA · CareDx, Inc.
Effective
2022-09-07
Filed
September 7, 2022, 7:59 PM ET
Effective September 7, 2022, the Company appointed Abraham Ronai, age 49, as the Company’s Chief Administrative & Legal Officer and Secretary.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Abhishek Jain was appointed as Chief Financial Officer at CareDx, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Effective September 7, 2022, CareDx, Inc. (the “Company”) appointed Abhishek Jain, age 46, as the Company’s Chief Financial Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Abraham Ronai was appointed as Chief Administrative & Legal Officer and Secretary at CareDx, Inc..

Action
appointed
Role
Chief Administrative & Legal Officer and Secretary
Exact text from the filing
Effective September 7, 2022, the Company appointed Abraham Ronai, age 49, as the Company’s Chief Administrative & Legal Officer and Secretary.
View on SEC.gov

CareDx, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-22-239989
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.